Cross Country Healthcare, Inc.
Cross Country Healthcare, Inc. is a U.S.-based provider specializing in talent management and consultative advisory services for healthcare organizations. The company operates through two main divisions: Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment offers a broad range of…
1D
+0.0%
1W
+0.0%
1M
+0.2%
6M
+43.7%
YTD
+63.6%
1Y
-4.1%
2Y
-19.8%
5Y
-19.0%
10Y
-9.4%
Next earnings date
No date known
Volatility around earnings
~80% stronger price swings than usual
PRICE TARGET LOW
US$8.65
CONSENSUS
US$12.09
MEDIAN
US$11.00
PRICE TARGET HIGH
US$21.00
0
STRONG BUY
2
BUY
12
HOLD
0
SELL
0
STRONG SELL
14
TOTAL · Hold
As of: 08/06/2026
P/E
-4.34
P/B
1.33
EV/EBITDA
-4.74
RETURN ON EQUITY
-1.4%
NET MARGIN
-1.8%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
31/03/2026
FREE FLOAT
91.9%
FLOAT SHARES
29,697,549
AVG. DAILY VOLUME (30D)
575,390
Allen Dwayne
Bhamidipati Venkat
CASH W LARRY
FITZGERALD GALE S
FITZGERALD GALE S
Cross Country Healthcare, Inc. is a company in the Industrials sector, Staffing & Employment Services industry, headquartered in United States.
The CEO is Kevin Cronin Clark, the company employs around 1,106 people.
The IPO was on 25/10/2001; the stock trades on NASDAQ under the ticker CCRN.
14 analysts rate the stock, the consensus is Hold (as of 08/06/2026).
The average price target is US$12.09, ranging from US$8.65 to US$21.00, with a median of US$11.00.
This is an external assessment, not a statement by Market Jury.
Around past earnings, price swings were roughly 80% stronger than usual.
No, Cross Country Healthcare currently does not pay a dividend.
Comparable stocks include Paychex, Robert Half, TriNet Group, ManpowerGroup, Kforce, Kelly Services, TrueBlue and Adecco Group.
Clicking "Analyze stock" lets five strategies assess Cross Country Healthcare against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.